Dr. med. et lic. iur. HSGPartnerPhone +41 58 658 29 15andreas.wildi@walderwyss.com

An dre as Wil di, born in 1972, is a me di ‐cal doc tor and an at tor ney at law. Hecon sults and re pres ents Dow Jo nes andNasdaq listed mul ti na tio nal com pa niesas well as mid- and small cap en ter pri ‐ses in the Life Sci en ces sec tor. He main ‐ly fo cu ses on Swiss and in ter na tio nalreim bur se ment & pricing law of phar ‐ma ceu ti cals and other the ra peu tic pro ‐ducts. Re gu la to ry is su es of phar ma ceu ‐ti cals, me di cal de vices, spe cial nu tri ti on,cos me tics, ge ne tic tes ting, stem cell-and blood pro ducts are his fur ther keyareas of prac ti se.

An dre as Wil di stu di ed me di ci ne at theUni ver si ty of Zu rich and gra dua ted asme di cal doc tor (MD). Working part-timein hos pi tal, GP-prac ti ce and on in ter na ‐tio nal res cue mis si ons, he com ple tedhis law de gree at the Uni ver si ty of St.Gal len HSG (MLaw). Be fo re pas sing thebar exam, he gai ned his first pro fes sio ‐nal le gal ex pe ri ence as clerk with theCan to nal Court of Schaff hau sen andwith a re cognis ed busi ness law firm inZu rich. From his first po si ti on as an at ‐tor ney at law in a lar ge Zu rich busi nesslaw firm, An dre as Wil di was as ked towork for the Swiss Go vern ment, whe rehe led the phar ma ceu ti cal reim bur se ‐ment & pricing unit in the Fe de ral Of ficeof Pu blic Health. The reaf ter, An dre asWil di broa den ed his mar ket ac cess ex ‐per ti se in ter na tio nal ly, as EMEA mar ketac cess law di rec tor for Jans sen Phar ‐ma ceu ti cals (John son & John son). Sin ce2012, he has built up his le gal prac ti sein a lar ge, well ac cep ted Zu rich busi ‐ness law firm. In 2015, Wal der Wysselec ted An dre as Wil di as their part ner.

An dre as Wil di works in Ger man, Frenchand English. He is ad mit ted to all SwissCourts and guest lec tu rer on phar ma ‐ceu ti cal law at the Uni ver si ty of Lu cer ‐ne’s Fa cul ty of Law.

Andreas Wildi

Walder Wyss Ltd.attorneys at law

Phone +41 58 658 58 58Fax +41 58 658 59 59reception@walderwyss.com

www.walderwyss.comZurich, Geneva, Basel, Bern, Lausanne, Lugano

Liberté de choix de la thérapie vsprincipe du caractère économique dansle domaine de la liste des spécialitésby Andreas Wildi, Daniel Staffelbach andStephanie EggimannNovember 2020

Therapiewahlfreiheit vs.Wirtschaftlichkeitsgebot im Bereich derSpezialitätenlisteby Andreas Wildi, Daniel Staffelbach andStephanie EggimannNovember 2020

Chapter 16: Switzerlandby Andreas Wildi [co-author], Markus R.Frick [co-author], Marija Petrovic [co-author], Benno Fischer-Siddiqui [co-author] and Monika Kawa [co-author]in: van Wyk/Kleyn (Ed.) (Editor[s]),"International Pharmaceutical Law andPractice" 2018

Chapter 16: Switzerlandby Andreas Wildi [co-author], Markus R.Frick [co-author], Marija Petrovic [co-author], Benno Fischer-Siddiqui [co-author] and Monika Kawa [co-author]in: van Wyk/Kleyn (Ed.) (Editor[s]),"International Pharmaceutical Law andPractice" 2017

Update: Postponement of EU MedicalDevice Regulation implementation dueto COVID-19by Andreas Wildi and Monja SieberMay 2020

The Life Sciences Law Review Chapter28 - Switzerlandby Andreas Wildi and Celine Weberin: The Life Sciences Law Review - 8thEdition, pp. 412 - 525, May 2020

Postponement of EU Medical DeviceRegulation implementation due toCOVID-19by Andreas Wildi and Monja SieberApril 2020

For a complete list of publicationsplease visit our website:www.walderwyss.com/andreas.wildi

Selected Publications